The Clorox Company (NYSE:CLX) Stock Position Raised by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX) by 9.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,242 shares of the company’s stock after acquiring an additional 200 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Clorox were worth $306,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Core Wealth Advisors Inc. bought a new stake in shares of Clorox during the 4th quarter worth $29,000. Innealta Capital LLC purchased a new stake in shares of Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC lifted its holdings in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. GoalVest Advisory LLC purchased a new stake in shares of Clorox in the first quarter valued at $31,000. Finally, First Foundation Advisors purchased a new stake in shares of Clorox in the first quarter valued at $31,000. 78.53% of the stock is owned by institutional investors.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.51% of the company’s stock.

Clorox Trading Down 0.8 %

Clorox stock opened at $163.43 on Thursday. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The business’s 50-day simple moving average is $148.06 and its 200-day simple moving average is $143.56. The firm has a market capitalization of $20.30 billion, a PE ratio of 84.68, a PEG ratio of 3.29 and a beta of 0.40. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Equities research analysts forecast that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.99%. This is a positive change from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date was Tuesday, August 13th. Clorox’s payout ratio is currently 252.85%.

Analyst Ratings Changes

CLX has been the subject of a number of research analyst reports. Wells Fargo & Company reduced their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Argus upgraded Clorox to a “hold” rating in a report on Tuesday, June 4th. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price objective for the company. DA Davidson reiterated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.